Which brain region(s) can be demyelinated by rapid infusion of normal saline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rapid Infusion of Normal Saline and Osmotic Demyelination

Rapid correction of chronic hyponatremia with normal saline can cause osmotic demyelination syndrome (ODS), which primarily affects the pons (central pontine myelinolysis) and extrapontine regions including the basal ganglia, thalamus, cerebellum, and cerebral white matter.

Brain Regions Affected by Osmotic Demyelination

The demyelination occurs in characteristic anatomical locations:

  • Central pons (central pontine myelinolysis) - most common site
  • Extrapontine regions including:
    • Basal ganglia
    • Thalamus
    • Cerebellum
    • Cerebral white matter
    • Midbrain

1

Critical Mechanism and Clinical Context

The key issue is not the normal saline itself, but the rate of sodium correction in patients with chronic hyponatremia. When normal saline is administered rapidly to patients with severe chronic hyponatremia, it can raise serum sodium too quickly, triggering ODS 2, 3.

The Pathophysiology

The sequence of injury involves:

  1. Rapid osmotic shifts trigger astrocyte apoptosis in vulnerable brain regions
  2. Disruption of astrocyte-oligodendrocyte networks occurs
  3. Secondary inflammation and microglial activation follow
  4. Demyelination results 2-7 days after rapid correction 4

Clinical Presentation

ODS typically presents with a biphasic course 2:

  • Initial improvement as hyponatremia corrects
  • Clinical deterioration 2-7 days later with:
    • Dysarthria
    • Dysphagia
    • Oculomotor dysfunction
    • Quadriparesis
    • Seizures or encephalopathy

Critical Safety Thresholds

To prevent ODS, sodium correction must be controlled 2:

  • Standard risk patients: Increase sodium by 4-8 mEq/L per day, not exceeding 10-12 mEq/L in 24 hours
  • High-risk patients (advanced liver disease, alcoholism, malnutrition, severe metabolic derangements): Increase sodium by 4-6 mEq/L per day, not exceeding 8 mEq/L in 24 hours

Important Clinical Caveat

A documented case showed that administering 2 L/day of normal saline to a patient with profound chronic hyponatremia (94 mmol/L) caused serum sodium to rise to 106 mmol/L within 18 hours—a rate of 12 mmol/L in 18 hours. This patient subsequently developed pontine and extrapontine myelinolysis with quadriplegia and respiratory failure 3.

Contrast with Hypertonic Saline

Interestingly, studies using hypertonic saline (3% and 23.4%) for raised intracranial pressure have not found evidence of osmotic demyelination, even with sodium levels reaching 169-170 mmol/L 5. This is because these patients typically do not have chronic hyponatremia—the critical risk factor is the rapid correction of chronic hyponatremia, not the absolute sodium level or the tonicity of the solution used.

Key Distinction

  • Acute hyponatremia (onset <48 hours): Can be corrected rapidly without ODS risk
  • Chronic hyponatremia: Requires gradual correction to avoid ODS 2

Practical Management

When treating chronic hyponatremia with volume depletion:

  1. Monitor sodium levels within 6 hours of starting any sodium-containing fluid
  2. Calculate the rate of sodium rise carefully
  3. If overcorrection occurs, consider relowering with electrolyte-free water or desmopressin 2
  4. In patients with concurrent hypokalemia, aggressive potassium replacement should be first-line therapy rather than aggressive sodium correction 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.